EUVIMEDEUVIMED entdecken
Crossref

Histone methyltransferase enzyme enhancer of zeste homolog 2 counteracts ischemic brain injury via H3K27me3 ‐mediated regulation of PI3K / AKT / mTOR signaling pathway

Miao Chen, Limin Fan, Guoping Wu, Hairong Wang, Shuo Gu iD

Environmental Toxicology · 2023

DOI: 10.1002/tox.23863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2023. Verfasst von Miao Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The First Affiliated Hospital of Hainan Medical University, Haikou, People's Republic of China. Hauptthemen laut MEDLINE: Brain Injuries, Neuroprotective Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Hainan Province Clinical Medical Center, Finance Science and Technology Project of Hainan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epigenetic histone methylation plays a crucial role in cerebral ischemic injury, particularly in the context of ischemic stroke. However, the complete understanding of regulators involved in histone methylation, such as Enhancer of Zeste Homolog 2 (EZH2), along with their functional effects and underlying mechanisms, remains incomplete.

Methods

Here, we employed a rat model of MCAO (Middle cerebral artery occlusion) and an OGD (Oxygen‐Glucose Deprivation) model of primary cortical neurons to study the role of EZH2 and H3K27me3 in cerebral ischemia‐reperfusion injury. The infarct volume was measured through TTC staining, while cell apoptosis was detected using TUNEL staining. The mRNA expression levels were quantified through quantitative real‐time polymerase chain reaction (qPCR), whereas protein expressions were evaluated via western blotting and immunofluorescence experiments.

Results

The expression levels of EZH2 and H3K27me3 were upregulated in OGD; these expression levels were further enhanced by GSK‐J4 but reduced by EPZ‐6438 and AKT inhibitor (LY294002) under OGD conditions. Similar trends were observed for mTOR, AKT, and PI3K while contrasting results were noted for UTX and JMJD3. The phosphorylation levels of mTOR, AKT, and PI3K were activated by OGD, further stimulated by GSK‐J4, but inhibited by EPZ‐6438 and AKT inhibitor. Inhibition of EZH2 or AKT effectively counteracted OGD‐/MCAO‐induced cell apoptosis. Additionally, inhibition of EZH2 or AKT mitigated MCAO‐induced infarct size and neurological deficit in vivo.

Conclusions

Collectively, our results demonstrate that EZH2 inhibition exerts a protective effect against ischemic brain injury by modulating the H3K27me3/PI3K/AKT/mTOR signaling pathway. The results provide novel insights into potential therapeutic mechanisms for stroke treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain InjuriesNeuroprotective AgentsAnimalsRatsEnhancer of Zeste Homolog 2 ProteinHistonesInfarctionPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRats, Sprague-DawleySignal TransductionTOR Serine-Threonine KinasesBenzamidesBiphenyl CompoundsMorpholinesPyridones

Stichwörter der Autor:innen

AKTEZH2H3K27me3MCAOOGD/RPI3Kcerebral ischemia-reperfusion injuryhistone methylationmTOR

Substanzen

Enhancer of Zeste Homolog 2 ProteinHistonesNeuroprotective AgentsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesmTOR protein, rattazemetostatBenzamidesBiphenyl Compounds

Autor:innen und Institutionen

  • Department of Emergency, The First Affiliated Hospital of Hainan Medical University, Haikou, People's Republic of China.
  • The Institute for Biomedical Engineering and Nano Science, Tongji University School of Medicine, Shanghai, People's Republic of China.
  • Department of Emergency, Sansha People's Hospital, Sansha, People's Republic of China.
  • Department of Emergency, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Department of Pediatric Neurosurgery, The First Affiliated Hospital of Hainan Medical University, Haikou, People's Republic of China.

ORCID-Profile: Shuo Gu

Förderung

  • Hainan Province Clinical Medical Center
  • Finance Science and Technology Project of Hainan Province

Zitieren

APA

Chen, M., Fan, L., Wu, G., Wang, H., & Gu, S. (2023). Histone methyltransferase enzyme enhancer of zeste homolog 2 counteracts ischemic brain injury via H3K27me3 ‐mediated regulation of PI3K / AKT / mTOR signaling pathway. Environmental Toxicology. https://doi.org/10.1002/tox.23863

Vancouver

Chen M, Fan L, Wu G, Wang H, Gu S. Histone methyltransferase enzyme enhancer of zeste homolog 2 counteracts ischemic brain injury via H3K27me3 ‐mediated regulation of PI3K / AKT / mTOR signaling pathway. Environmental Toxicology. 2023. doi:10.1002/tox.23863

BibTeX
@article{Chen2023,
  author = {Chen, Miao and Fan, Limin and Wu, Guoping and Wang, Hairong and Gu, Shuo},
  title = {Histone methyltransferase enzyme enhancer of zeste homolog 2 counteracts ischemic brain injury via H3K27me3 ‐mediated regulation of PI3K / AKT / mTOR signaling pathway},
  journal = {Environmental Toxicology},
  year = {2023},
  doi = {10.1002/tox.23863}
}
Kostenlos starten →